[18F]FAPI-74 serving as complementary diagnostic in Avacta Phase 1 trial
May 23, 2024 – SOFIE is pleased to partner with Avacta through Avacta’s use […]
May 23, 2024 – SOFIE is pleased to partner with Avacta through Avacta’s use […]
Lennert Eismann, Stephan T Ledderose, Benazir Enzinger, Elena Berg, Thilo Westhofen, Severin Rodler, Gerald B […]
Helena Lanzafame, Ilektra A Mavroeidi, Kim M Pabst, Mélanie Desaulniers, Marc Ingenwerth, Nader Hirmas, Lukas […]
Marinus J Hagens, Pim J van Leeuwen, Maurits Wondergem, Thierry N Boellaard, Francesco Sanguedolce, Daniela […]
David Kersting, Silvia Morbelli, Sophie E. M. Veldhuijzen van Zanten & Hein J. Verberne
Presented by: Sherly Mosessian, PhD, SOFIE Chief Scientific Officer
7th Theranostics World Congress – Santiago, Chile
March […]
A WORD FROM OUR CHIEF SCIENTIFIC OFFICER
Dear FAPI Community,
We are looking forward to a […]
Rainer Hamacher, Kim M Pabst, Phyllis F Cheung, Christoph E Heilig, Jennifer Hüllein, Sven-Thorsten Liffers, […]
Xiang Li, Na Lu, Lili Lin, Yiwen Chen, Shuye Yang, Huatao Wang, Xinyuan Liu, Chengyi […]
A WORD FROM OUR CHIEF SCIENTIFIC OFFICER